Cost Analysis: Port Delivery System versus Monthly Ranibizumab for Wet Age-Related Macular Degeneration Treatment
Publication information:
Al-Khersan H, Patel N, Yannuzzi N, Lin J, Smiddy W. Cost Analysis: Port Delivery System versus Monthly Ranibizumab for Wet Age-Related Macular Degeneration Treatment.
Ophthalmol Retina. 2022;6(11):1105–1106. PMID: 35636743